These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 24474802)

  • 21. Encapsulation and retention of chelated-copper inside hydrophobic nanoparticles: Liquid cored nanoparticles show better retention than a solid core formulation.
    Hervella P; Parra E; Needham D
    Eur J Pharm Biopharm; 2016 May; 102():64-76. PubMed ID: 26925504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of liposomal and NLC (nanostructured lipid carrier) formulations for improving the transdermal delivery of oxaprozin: Effect of cyclodextrin complexation.
    Mennini N; Cirri M; Maestrelli F; Mura P
    Int J Pharm; 2016 Dec; 515(1-2):684-691. PubMed ID: 27825863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of cyclodextrin complexation on the liposome permeability of a model hydrophobic weak Acid.
    Joguparthi V; Anderson BD
    Pharm Res; 2008 Nov; 25(11):2505-15. PubMed ID: 18642063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel sulfobutyl ether cyclodextrin gradient leads to highly active liposomal irinotecan formulation.
    Li C; Cui J; Wang C; Li Y; Zhang L; Xiu X; Li Y; Wei N; Zhang L; Wang P
    J Pharm Pharmacol; 2011 Jun; 63(6):765-73. PubMed ID: 21585373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liposomes as carriers of antitumor agents: toward a clinical reality.
    Perez-Soler R
    Cancer Treat Rev; 1989 Jun; 16(2):67-82. PubMed ID: 2670206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sulfated and non-sulfated amphiphilic-beta-cyclodextrins: impact of their structural properties on the physicochemical properties of nanoparticles.
    Abdelwahed W; Degobert G; Dubes A; Parrot-Lopez H; Fessi H
    Int J Pharm; 2008 Mar; 351(1-2):289-95. PubMed ID: 18063493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of solubilizing agents on mupirocin loading into and release from PEGylated nanoliposomes.
    Cern A; Nativ-Roth E; Goldblum A; Barenholz Y
    J Pharm Sci; 2014 Jul; 103(7):2131-2138. PubMed ID: 24898012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microfluidic manufacturing of phospholipid nanoparticles: Stability, encapsulation efficacy, and drug release.
    Guimarães Sá Correia M; Briuglia ML; Niosi F; Lamprou DA
    Int J Pharm; 2017 Jan; 516(1-2):91-99. PubMed ID: 27840162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor vascular targeted liposomal-bortezomib minimizes side effects and increases therapeutic activity in human neuroblastoma.
    Zuccari G; Milelli A; Pastorino F; Loi M; Petretto A; Parise A; Marchetti C; Minarini A; Cilli M; Emionite L; Di Paolo D; Brignole C; Piaggio F; Perri P; Tumiatti V; Pistoia V; Pagnan G; Ponzoni M
    J Control Release; 2015 Aug; 211():44-52. PubMed ID: 26031842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanoparticles for the delivery of zoledronic acid to prostate cancer cells: a comparative analysis through time lapse video-microscopy technique.
    Schiraldi C; Zappavigna S; D' Agostino A; Porto S; Gaito O; Lusa S; Lamberti M; De Rosa M; De Rosa G; Caraglia M
    Cancer Biol Ther; 2014; 15(11):1524-32. PubMed ID: 25482949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increasing the stability of curcumin in serum with liposomes or hybrid drug-in-cyclodextrin-in-liposome systems: a comparative study.
    Matloob AH; Mourtas S; Klepetsanis P; Antimisiaris SG
    Int J Pharm; 2014 Dec; 476(1-2):108-15. PubMed ID: 25269006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins.
    Fuhrmann G; Serio A; Mazo M; Nair R; Stevens MM
    J Control Release; 2015 May; 205():35-44. PubMed ID: 25483424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-tumor activity of liposome encapsulated fluoroorotic acid as a single agent and in combination with liposome irinotecan.
    Riviere K; Kieler-Ferguson HM; Jerger K; Szoka FC
    J Control Release; 2011 Aug; 153(3):288-96. PubMed ID: 21600250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relevancy of drug loading to liposomal formulation therapeutic efficacy.
    Barenholz Y
    J Liposome Res; 2003 Feb; 13(1):1-8. PubMed ID: 12725720
    [No Abstract]   [Full Text] [Related]  

  • 35. Hydrogel-based drug carriers for controlled release of hydrophobic drugs and proteins.
    Peng K; Tomatsu I; Kros A
    J Control Release; 2011 Nov; 152 Suppl 1():e72-4. PubMed ID: 22195937
    [No Abstract]   [Full Text] [Related]  

  • 36. A simple passive equilibration method for loading carboplatin into pre-formed liposomes incubated with ethanol as a temperature dependent permeability enhancer.
    Wehbe M; Malhotra A; Anantha M; Roosendaal J; Leung AWY; Plackett D; Edwards K; Gilabert-Oriol R; Bally MB
    J Control Release; 2017 Apr; 252():50-61. PubMed ID: 28286316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Active methods of drug loading into liposomes: recent strategies for stable drug entrapment and increased in vivo activity.
    Gubernator J
    Expert Opin Drug Deliv; 2011 May; 8(5):565-80. PubMed ID: 21492058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanosponge-encapsulated camptothecin exerts anti-tumor activity in human prostate cancer cells.
    Minelli R; Cavalli R; Ellis L; Pettazzoni P; Trotta F; Ciamporcero E; Barrera G; Fantozzi R; Dianzani C; Pili R
    Eur J Pharm Sci; 2012 Nov; 47(4):686-94. PubMed ID: 22917641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microfluidics based manufacture of liposomes simultaneously entrapping hydrophilic and lipophilic drugs.
    Joshi S; Hussain MT; Roces CB; Anderluzzi G; Kastner E; Salmaso S; Kirby DJ; Perrie Y
    Int J Pharm; 2016 Nov; 514(1):160-168. PubMed ID: 27863660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liposome production and concurrent loading of drug simulants by microfluidic hydrodynamic focusing.
    Lin WS; Malmstadt N
    Eur Biophys J; 2019 Sep; 48(6):549-558. PubMed ID: 31327019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.